Indevus Pharmaceuticals Inc. of Lexington reported first quarter revenue of $11.2 million, and a $12.4 million net loss.
During the same period the previous year, the company reported revenue of $14.4 million and a net loss of $11.2 million.
For the six months ended March 31, Indevus reported revenue of $24.4 million and a net loss of $23.2 million.
The company acquired Valera Pharmaceuticals in April.
Indevus acquires, researches and develops urology and endocrinology drugs.
